Gilead Historical Income Statement

GILD Stock  USD 73.01  0.60  0.83%   
Historical analysis of Gilead Sciences income statement accounts such as Gross Profit of 28.5 B or Other Operating Expenses of 20.5 B can show how well Gilead Sciences performed in making a profits. Evaluating Gilead Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Gilead Sciences's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Gilead Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gilead Sciences is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

About Gilead Income Statement Analysis

Gilead Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Gilead Sciences shareholders. The income statement also shows Gilead investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Gilead Sciences Income Statement Chart

Gilead Sciences Income Statement is one of the three primary financial statements used for reporting Gilead's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Gilead Sciences revenue and expense. Gilead Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Gilead Sciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 20.5 B, whereas Interest Expense is forecasted to decline to about 534.5 M.

Total Revenue

Total revenue comprises all receipts Gilead Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Gilead Sciences minus its cost of goods sold. It is profit before Gilead Sciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Gilead Sciences. It is also known as Gilead Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Gilead Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.At present, Gilead Sciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 20.5 B, whereas Interest Expense is forecasted to decline to about 534.5 M.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Gilead Sciences income statement Correlations

0.430.210.010.040.250.250.370.140.130.22-0.020.190.440.18-0.140.010.060.17-0.38-0.050.130.0-0.31-0.220.65
0.430.770.680.770.390.40.480.780.80.33-0.10.220.370.770.680.320.130.080.22-0.110.050.56-0.440.37-0.02
0.210.770.980.80.70.710.760.850.780.65-0.090.610.290.680.810.110.59-0.090.27-0.11-0.110.43-0.10.4-0.3
0.010.680.980.810.660.680.70.820.770.62-0.10.580.20.650.850.120.6-0.130.35-0.11-0.150.44-0.010.46-0.44
0.040.770.80.810.140.170.230.950.990.12-0.150.12-0.140.910.950.540.13-0.090.48-0.45-0.430.84-0.030.69-0.57
0.250.390.70.660.141.00.990.260.130.970.140.90.650.080.2-0.50.860.1-0.140.360.39-0.31-0.16-0.190.2
0.250.40.710.680.171.00.990.280.160.970.120.90.640.10.23-0.480.860.08-0.120.340.36-0.29-0.14-0.160.18
0.370.480.760.70.230.990.990.350.230.950.10.880.650.170.26-0.410.830.08-0.120.290.32-0.21-0.17-0.130.21
0.140.780.850.820.950.260.280.350.910.24-0.10.220.010.80.920.410.2-0.20.5-0.33-0.340.75-0.090.69-0.51
0.130.80.780.770.990.130.160.230.910.1-0.170.11-0.120.960.890.560.1-0.010.38-0.48-0.420.84-0.070.62-0.47
0.220.330.650.620.120.970.970.950.240.10.360.940.630.080.16-0.520.910.24-0.080.370.42-0.35-0.17-0.190.15
-0.02-0.1-0.09-0.1-0.150.140.120.1-0.1-0.170.360.370.19-0.05-0.23-0.290.380.710.150.260.41-0.32-0.25-0.17-0.01
0.190.220.610.580.120.90.90.880.220.110.940.370.360.110.13-0.440.980.25-0.130.10.2-0.280.08-0.140.12
0.440.370.290.2-0.140.650.640.650.01-0.120.630.190.36-0.14-0.1-0.530.280.19-0.180.810.77-0.47-0.71-0.430.44
0.180.770.680.650.910.080.10.170.80.960.08-0.050.11-0.140.750.520.10.220.22-0.53-0.370.76-0.110.46-0.34
-0.140.680.810.850.950.20.230.260.920.890.16-0.230.13-0.10.750.490.16-0.280.6-0.31-0.370.780.010.76-0.68
0.010.320.110.120.54-0.5-0.48-0.410.410.56-0.52-0.29-0.44-0.530.520.49-0.38-0.210.36-0.65-0.560.870.060.63-0.4
0.060.130.590.60.130.860.860.830.20.10.910.380.980.280.10.16-0.380.23-0.060.090.16-0.260.12-0.11-0.03
0.170.08-0.09-0.13-0.090.10.080.08-0.2-0.010.240.710.250.190.22-0.28-0.210.23-0.230.090.42-0.23-0.38-0.460.3
-0.380.220.270.350.48-0.14-0.12-0.120.50.38-0.080.15-0.13-0.180.220.60.36-0.06-0.23-0.03-0.190.480.040.74-0.73
-0.05-0.11-0.11-0.11-0.450.360.340.29-0.33-0.480.370.260.10.81-0.53-0.31-0.650.090.09-0.030.81-0.68-0.56-0.460.22
0.130.05-0.11-0.15-0.430.390.360.32-0.34-0.420.420.410.20.77-0.37-0.37-0.560.160.42-0.190.81-0.6-0.71-0.610.45
0.00.560.430.440.84-0.31-0.29-0.210.750.84-0.35-0.32-0.28-0.470.760.780.87-0.26-0.230.48-0.68-0.60.050.76-0.54
-0.31-0.44-0.1-0.01-0.03-0.16-0.14-0.17-0.09-0.07-0.17-0.250.08-0.71-0.110.010.060.12-0.380.04-0.56-0.710.050.35-0.23
-0.220.370.40.460.69-0.19-0.16-0.130.690.62-0.19-0.17-0.14-0.430.460.760.63-0.11-0.460.74-0.46-0.610.760.35-0.66
0.65-0.02-0.3-0.44-0.570.20.180.21-0.51-0.470.15-0.010.120.44-0.34-0.68-0.4-0.030.3-0.730.220.45-0.54-0.23-0.66
Click cells to compare fundamentals

Gilead Sciences Account Relationship Matchups

Gilead Sciences income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.9B1.5B2.1B3.1B(1.8B)(1.7B)
Interest Expense995M984M1.0B935M944M534.5M
Total Revenue22.4B24.7B27.3B27.3B27.1B28.5B
Gross Profit17.8B20.1B20.7B21.6B27.1B28.5B
Other Operating Expenses18.2B14.8B17.2B16.3B19.5B20.5B
Operating Income4.3B7.0B7.4B7.3B7.6B4.4B
Ebit4.3B7.0B7.4B7.3B7.6B4.4B
Ebitda6.2B8.5B9.5B10.4B7.6B4.9B
Cost Of Revenue4.7B4.6B6.6B5.7B5.8B6.1B
Total Operating Expenses13.5B10.2B10.6B10.7B11.8B12.4B
Income Before Tax5.2B1.7B8.3B5.8B6.9B4.2B
Total Other Income Expense Net873M(5.4B)872M(1.5B)(746M)(708.7M)
Net Income5.4B89M6.2B4.6B5.7B3.0B
Income Tax Expense(204M)1.6B2.1B1.2B(1.2B)(1.2B)
Research Development9.1B5.0B5.4B5.0B5.7B6.0B
Selling General Administrative3.6B4.4B4.5B4.9B6.5B6.8B
Net Income Applicable To Common Shares5.4B123M6.2B4.6B5.3B4.9B
Net Income From Continuing Ops5.4B89M6.2B4.6B5.8B6.6B
Non Operating Income Net Other1.9B(1.4B)(639M)(581M)(522.9M)(496.8M)
Minority Interest(22M)(34M)24M26M47M49.4M
Tax Provision(204M)1.6B2.1B1.2B1.4B2.2B
Net Interest Income(995M)(984M)(1.0B)(935M)(918M)(963.9M)
Reconciled Depreciation1.4B1.5B2.1B2.1B2.5B1.9B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.